(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.
The vaccine generated immune responses similar to those seen in the minority of people who are naturally able to clear any infection with the hepatitis C virus
The findings suggest it might be possible to develop a vaccine that will be broadly effective against hepatitis C and offer lasting protection.
The researchers are hopeful that in time, this work could lead to a vaccine that protects those at risk from the disease or helps in treating those with hepatitis C infections. They caution that many more studies over a number of years would be needed in developing such a vaccine.